Gyala Therapeutics

top of page

Gyala Therapeutics
Science
Funding
Team
Partners
Contact
News
Cookies policy
More

Use tab to navigate through the menu items.

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investme

Gyala | Science | Partners | Team | Contact

Gyala Therapeutics develops cell therapies for the treatment of hematological malignancies with clinical unmet need.

Gyala - All rights reserved © 2024

Follow us

bottom of page